Citation 67794

JIMENEZ,C: QUINOA,E: ADAMCZESKI,M: HUNTER,LM: CREWS,P:. (1991). NOVEL SPONGE-DERIVED AMINO ACIDS. 12. TRYPTOPHAN-DERIVED PIGMENTS AND ACCOMPANYING SESTERTERPENES FROM FASCAPLYSINOPIS RETICULATA.. 56(10)

Citation Details

Title	NOVEL SPONGE-DERIVED AMINO ACIDS. 12. TRYPTOPHAN-DERIVED PIGMENTS AND ACCOMPANYING SESTERTERPENES FROM FASCAPLYSINOPIS RETICULATA.
Authors	JIMENEZ,C: QUINOA,E: ADAMCZESKI,M: HUNTER,LM: CREWS,P:
Year	1991
Volume	56
Issue	10

Summary

Year: 1991

Journal: Unknown

Organisms and Their Experiments (1)

Fascaplysinopsis reticulata (THORECTIDAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
5	ANTIYEAST ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
6	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
7	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LUFFARIELLOLIDE,ISO: DEHYDRO:	None
8	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUFFARIELLOLIDE,ISO: DEHYDRO:	WEAK ACTIVITY
9	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LUFFARIELLOLIDE,DEHYDRO: DIACID	None
10	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUFFARIELLOLIDE,DEHYDRO: DIACID	WEAK ACTIVITY
11	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FASCAPLYSIN A	None
12	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FASCAPLYSIN A	WEAK ACTIVITY
13	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FASCAPLYSIN A,HOMO: CATION	None
14	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FASCAPLYSIN C,HOMO:	None
15	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FASCAPLYSIN B,HOMO:	None
16	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FASCAPLYSIN A,SECO:	None
17	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	OCTOPAMINE,(+):	None
18	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FASCAPLYSIN	None

Show SPARQL Queries (1)